Ageing and muscular dystrophy differentially affect murine pharyngeal muscles in a region-dependent manner

Journal of Physiology

Volumn 592, Issue 23, 2014, Pages 5301-5315

  Randolph, Matthew E ^a   Luo, Qingwei ^b   Ho, Justin ^a   Vest, Katherine E ^a   Sokoloff, Alan J ^b   Pavlath, Grace K ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POLYADENYLATE BINDING NUCLEAR PROTEIN 1; RNA BINDING PROTEIN; UNCLASSIFIED DRUG; MUTANT PROTEIN; MYOSIN HEAVY CHAIN; PEPTIDE; POLYADENYLIC ACID BINDING PROTEIN; POLYALANINE;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DYSPHAGIA; FEMALE; MALE; MOUSE; MUSCLE ATROPHY; MUSCLE CELL; MUSCLE GROWTH; NONHUMAN; OCULOPHARYNGEAL MUSCULAR DYSTROPHY; PALATOPHARYNGEUS MUSCLE; PHARYNGEAL MUSCLE; PRIORITY JOURNAL; ANIMAL; ANIMAL MUSCULAR DYSTROPHY; C57BL MOUSE; DISEASE MODEL; GENETICS; HUMAN; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SKELETAL MUSCLE; SWALLOWING; TRANSGENIC MOUSE; TRINUCLEOTIDE REPEAT; UPREGULATION;

AGING; ANIMALS; DEGLUTITION; DEGLUTITION DISORDERS; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MUSCLE FIBERS, SKELETAL; MUSCULAR ATROPHY; MUSCULAR DYSTROPHY, ANIMAL; MUSCULAR DYSTROPHY, OCULOPHARYNGEAL; MUTANT PROTEINS; MYOSIN HEAVY CHAINS; PEPTIDES; PHARYNGEAL MUSCLES; POLY(A)-BINDING PROTEIN I; TRINUCLEOTIDE REPEAT EXPANSION; UP-REGULATION;

EID: 84918819786     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2014.280420     Document Type: Article

References (68)

1. Aherne W, Ayyar DR, Clarke PA & Walton JN (1971). Muscle fiber size in normal infants, children and adolescents. An autopsy study. J Neurol Sci 14, 171-182.
2. Aloysius A, Born P, Kinali M, Davis T, Pane M & Mercuri E (2008). Swallowing difficulties in Duchenne muscular dystrophy: indications for feeding assessment and outcome of videofluroscopic swallow studies. Eur J Paediatr Neurol 12, 239-245.
3. Anvar SY, Raz Y, Verway N, van der Sluijs B, Venema A, Goeman JJ, Vissing J, van der Maarel SM, t Hoen PAC, van Engelen BGM & Raz V (2013). A decline in PABPN1 induces progressive muscle weakness in oculopharyngeal muscle dystrophy and in muscle aging. Aging (Albany NY) 5, 412-426.
4. Apponi LH, Corbett AH & Pavlath GK (2013). Control of mRNA stability contributes to low levels of nuclear poly(A) binding protein 1 (PABPN1) in skeletal muscle. Skelet Muscle 3, 23.
5. Apponi LH, Leung SW, Williams KR, Valentini SR, Corbett AH & Pavlath GK (2010). Loss of nuclear poly(A)-binding protein 1 causes defects in myogenesis and mRNA biogenesis. Hum Mol Genet 19, 1058-1065.
6. Bachmann G, Streppel M, Krug B & Neuen-Jacob E (2001). Cricopharyngeal muscle hypertrophy associated with florid myositis. Dysphagia 16, 244-248.
7. Banerjee A, Apponi LH, Pavlath GK & Corbett AH (2013). PABPN1: molecular function and muscle disease. FEBS J 280, 4230-4250.
8. Blakeley WR, Garety EJ & Smith DE (1968). Section of the cricopharyngeus muscle for dysphagia. Arch Surg 96, 745-762.
9. Bloem BR, Lagaay AM, van Beek W, Haan J, Roos RA & Wintzen AR (1990). Prevalence of subjective dysphagia in community residents aged over 87. BMJ 300, 721-722.
10. Brais B, Bouchard JP, Xie YG, Rochefort DL, Chrétien N, Tomé FM, Lafrenière RG, Rommens JM, Uyama E, Nohira O, Blumen S, Korczyn AD, Heutink P, Mathieu J, Duranceau A, Codère F, Fardeau M, Rouleau GA & Korcyn AD (1998). Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy. Nat Genet 18, 164-167.
11. Bredman JJ, Weijs WA, Korfage HA, Brugman P & Moorman AF (1992). Myosin heavy chain expression in rabbit masseter muscle during postnatal development. J Anat 180 (Pt 2), 263-274.
12. Butler-Browne GS, Eriksson PO, Laurent C & Thornell LE (1988). Adult human masseter muscle fibers express myosin isozymes characteristic of development. Muscle Nerve 11, 610-620.
13. Davies JE, Wang L, Garcia-Oroz L, Cook LJ, Vacher C, O'Donovan DG & Rubinsztein DC (2005). Doxycycline attenuates and delays toxicity of the oculopharyngeal muscular dystrophy mutation in transgenic mice. Nat Med 11, 672-677.
14. Davies JE, Sarkar S & Rubinsztein DC (2008). Wild-type PABPN1 is anti-apoptotic and reduces toxicity of the oculopharyngeal muscular dystrophy mutation. Hum Mol Genet 17, 1097-1108.
15. Davis MV, Merati AL, Jaradeh SS & Blumin JH (2007). Myosin heavy chain composition and fiber size of the cricopharyngeus muscle in patients with achalasia and normal subjects. Ann Otol Rhinol Laryngol 116, 643-646.
16. Dayal VS & Freeman J (1976). Cricopharyngeal myotomy for dysphagia in oculopharyngeal muscular dystrophy. Report of a case. Arch Otolaryngol 102, 115-116.
17. Donner MW, Bosma JF & Robertson DL (1985). Anatomy and physiology of the pharynx. Gastrointest Radiol 10, 196-212.
18. Dutta CR & Basmajian JV (1960). Gross and histological structure of the pharyngeal constrictors in the rabbit. Anat Rec 137, 127-134.
19. Eicher PS, McDonald-Mcginn DM, Fox CA, Driscoll DA, Emanuel BS & Zackai EH (2000). Dysphagia in children with a 22q11.2 deletion: unusual pattern found on modified barium swallow. J Pediatr 137, 158-164.
20. Ekberg O, Ekman M, Eriksson LI, Malm R, Sundman E & Arner A (2009). An in vitro model for studying neuromuscular transmission in the mouse pharynx. Dysphagia 24, 32-39.
21. Ertekin C & Aydogdu I (2003). Neurophysiology of swallowing. Clin Neurophysiol 114, 2226-2244.
22. Ertekin C, Yuceyar N & Aydogdu I (1998). Clinical and electrophysiological evaluation of dysphagia in myasthenia gravis. J Neurol Neurosurg Psychiatry 65, 848-856.
23. Eslick GD & Talley NJ (2008). Dysphagia: epidemiology, risk factors and impact on quality of life - a population-based study. Aliment Pharmacol Ther 27, 971-979.
24. Gidaro T, Negroni E, Périé S, Mirabella M, Lainé J, Lacau St Guily J, Butler-Browne G, Mouly V & Trollet C (2013). Atrophy, fibrosis, and increased PAX7-positive cells in pharyngeal muscles of oculopharyngeal muscular dystrophy patients. J Neuropathol Exp Neurol 72, 234-243.
25. Himmelreich HA (1973). [The palatopharyngeal muscle of mammals]. Gegenbaurs Morphol Jahrb 119, 172-212.
26. Holland G, Jayasekeran V, Pendleton N, Horan M, Jones M & Hamdy S (2011). Prevalence and symptom profiling of oropharyngeal dysphagia in a community dwelling of an elderly population: a self-reporting questionnaire survey. Dis Esophagus 24, 476-480.
27. Hyodo M, Yumoto E, Kawakita S & Yamagata T (1999). Postnatal changes in the types of muscle fiber in the canine inferior pharyngeal constrictor. Acta Otolaryngol 119, 843-846.
28. Johnson BD, Wilson LE, Zhan WZ, Watchko JF, Daood MJ & Sieck GC (1994). Contractile properties of the developing diaphragm correlate with myosin heavy chain phenotype. J Appl Physiol 77, 481-487.
29. Kawashima K, Motohashi Y & Fujishima I (2004). Prevalence of dysphagia among community-dwelling elderly individuals as estimated using a questionnaire for dysphagia screening. Dysphagia 19, 266-271.
30. Kirberger RM, Steenkamp G, Spotswood TC, Boy SC, Miller DB & van Zyl M (2006). Stenotic nasopharyngeal dysgenesis in the dachshund: seven cases (2002-2004). J Am Anim Hosp Assoc 119, 290-297.
31. Leese G & Hopwood D (1986). Muscle fiber typing in the human pharyngeal constrictors and oesophagus: the effect of ageing. Acta Anat (Basel) 127, 77-80.
32. Lever TE, Gorsek A, Cox KT, O'Brien KF, Capra NF, Hough MS & Murashov AK (2009). An animal model of oral dysphagia in amyotrophic lateral sclerosis. Dysphagia 24, 180-195.
33. Lever TE, Simon E, Cox KT, Capra NF, O'Brien KF, Hough MS & Murashov AK (2010). A mouse model of pharyngeal dysphagia in amyotrophic lateral sclerosis. Dysphagia 25, 112-126.
34. Lexell J, Taylor CC & Sjöström M (1988). What is the cause of the ageing atrophy? Total number, size and proportion of different fiber types studied in whole vastus lateralis muscle from 15- to 83-year-old men. J Neurol Sci 84, 275-294.
35. Lindgren S & Janzon L (1991). Prevalence of swallowing complaints and clinical findings among 50-79-year-old men and women in an urban population. Dysphagia 6, 187-192.
36. Little BW & Perl DP (1982). Oculopharyngeal muscular dystrophy. An autopsied case from the French-Canadian kindred. J Neurol Sci 53, 145-158.
37. Logemann JA (2007). Swallowing disorders. Best Pract Res Clin Gastroenterol 21, 563-573.
38. Martin BJ, Corlew MM, Wood H, Olson D, Golopol LA, Wingo M & Kirmani N (1994). The association of swallowing dysfunction and aspiration pneumonia. Dysphagia 9, 1-6.
39. McLoon LK (1998). Muscle fiber type compartmentalization and expression of an immature myosin isoform in the sternocleidomastoid muscle of rabbits and primates. J Neurol Sci 156, 3-11.
40. McLoon LK & Wirtschafter JD (2002). Continuous myonuclear addition to single extraocular myofibers in uninjured adult rabbits. Muscle Nerve 25, 348-358.
41. McLoon LK & Wirtschafter J (2003). Activated satellite cells in extraocular muscles of normal adult monkeys and humans. Invest Ophthalmol Vis Sci 44, 1927-1932.
42. McLoon LK, Rowe J, Wirtschafter J & McCormick KM (2004). Continuous myofiber remodeling in uninjured extraocular myofibers: myonuclear turnover and evidence for apoptosis. Muscle Nerve 29, 707-715.
43. Miller AJ. (2008). The neurobiology of swallowing and dysphagia. Dev Disabil Res Rev 14, 77-86.
44. Montgomery WW & Lynch JP (1971). Oculopharyngeal muscular dystrophy treated by inferior constrictor myotomy. Trans Am Acad Ophthalmol Otolaryngol 75, 986-993.
45. Mootoosamy RC & Dietrich S (2002). Distinct regulatory cascades for head and trunk myogenesis. Development 129, 573-583.
46. Mu L & Sanders I (2002). Muscle fiber-type distribution pattern in the human cricopharyngeus muscle. Dysphagia 17, 87-96.
47. Mu L, Su H, Wang J & Sanders I (2007). Myosin heavy chain-based fiber types in the adult human cricopharyngeus muscle. Muscle Nerve 35, 637-648.
48. Mu L, Sobotka S, Chen J, Su H, Sanders I, Adler CH, Shill HA, Caviness JN, Samanta JE, Beach TG & Consortium APasD (2012). Altered pharyngeal muscles in Parkinson disease. J Neuropathol Exp Neurol 71, 520-530.
49. Nakano T & Muto H (1985). Anatomical observations in the pharynx of the mouse with special reference to the nasopharyngeal hiatus (Wood Jones). Acta Anat (Basel) 121, 147-152.
50. Noden DM & Francis-West P (2006). The differentiation and morphogenesis of craniofacial muscles. Dev Dyn 235, 1194-1218.
51. Nozaki S, Umaki Y, Sugishita S, Tatara K, Adachi K & Shinno S (2007). Videofluorographic assessment of swallowing function in patients with Duchenne muscular dystrophy. Rinsho Shinkeigaku 47, 407-412.
52. Périé S, Mamchaoui K, Mouly V, Blot S, Bouazza B, Thornell L-E, St Guily JL & Butler-Browne G (2006). Premature proliferative arrest of cricopharyngeal myoblasts in oculo-pharyngeal muscular dystrophy: Therapeutic perspectives of autologous myoblast transplantation. Neuromuscul Disord 16, 770-781.
53. Prasse JE & Kikano GE (2009). An overview of pediatric dysphagia. Clin Pediatr 48, 247-251.
54. Raz V, Buijze H, Raz Y, Verwey N, Anvar SY, Aartsma-Rus A & van der Maarel SM (2014). A novel feed-forward loop between ARIH2 E3-ligase and PABPN1 regulates aging-associated muscle degeneration. Am J Pathol 184, 1119-1131.
55. Reiser PJ, Moss RL, Giulian GG & Greaser ML (1985a). Shortening velocity and myosin heavy chains of developing rabbit muscle fibers. J Biol Chem 260, 14403-14405.
56. Reiser PJ, Moss RL, Giulian GG & Greaser ML (1985b). Shortening velocity in single fibers from adult rabbit soleus muscles is correlated with myosin heavy chain composition. J Biol Chem 260, 9077-9080.
57. Robbins J, Langmore S, Hind JA & Erlichman M (2002). Dysphagia research in the 21st century and beyond: proceedings from Dysphagia Experts Meeting, August 21, 2001. J Rehabil Res Dev 39, 543-548.
58. Robinson DO, Hammans SR, Read SP & Sillibourne J (2005). Oculopharyngeal muscular dystrophy (OPMD): analysis of the PABPN1 gene expansion sequence in 86 patients reveals 13 different expansion types and further evidence for unequal recombination as the mutational mechanism. Hum Genet 116, 267-271.
59. Rubesin SE, Jessurun J, Robertson D, Jones B, Bosma JF & Donner MW (1987). Lines of the pharynx. Radiographics 7, 217-237.
60. Scapolo PA, Rowlerson A, Mascarello F & Veggetti A (1991). Neonatal myosin in bovine and pig tensor tympani muscle fibers. J Anat 178, 255-263.
61. Schmalbruch H (1976). The morphology of regeneration of skeletal muscles in the rat. Tissue Cell 8, 673-692.
62. Talmadge RJ & Roy RR (1993). Electrophoretic separation of rat skeletal muscle myosin heavy-chain isoforms. J Appl Physiol 75, 2337-2340.
63. Taylor EW (1915). Progressive vagus-glossopharyngeal paralysis with ptosis: contribution to group of family diseases. J Nerv Ment Dis 42, 129-139.
64. Trollet C, Anvar SY, Venema A, Hargreaves IP, Foster K, Vignaud A, Ferry A, Negroni E, Hourde C, Baraibar MA, 't Hoen PAC, Davies JE, Rubinsztein DC, Heales SJ, Mouly V, van der Maarel SM, Butler-Browne G, Raz V & Dickson G (2010). Molecular and phenotypic characterization of a mouse model of oculopharyngeal muscular dystrophy reveals severe muscular atrophy restricted to fast glycolytic fibers. Hum Mol Genet 19, 2191-2207.
65. Victor M, Hayes R & Adams RD (1962). Oculopharyngeal muscular dystrophy. A familial disease of late life characterized by dysphagia and progressive ptosis of the evelids. N Engl J Med 267, 1267-1272.
66. Wada KI, Katsuta S & Soya H (2003). Natural occurrence of myofiber cytoplasmic enlargement accompanied by decrease in myonuclear number. Jpn J Physiol 53, 145-150.
67. Wieczorek DF, Periasamy M, Butler-Browne GS, Whalen RG & Nadal-Ginard B (1985). Co-expression of multiple myosin heavy chain genes, in addition to a tissue-specific one, in extraocular musculature. J Cell Biol 101, 618-629.
68. Wirtschafter JD, Ferrington DA & McLoon LK (2004). Continuous remodeling of adult extraocular muscles as an explanation for selective craniofacial vulnerability in oculopharyngeal muscular dystrophy. J Neuroophthalmol 24, 62-67.